Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease
Autor: | Erin D. Shannon, Kate K. Orroth, Jason Exter, Katherine E Mues, Robert S. Rosenson, Elizabeth A. Jackson, Paul Muntner, Rebecca Zaha |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
0301 basic medicine medicine.medical_specialty Acute coronary syndrome Cardiology Disease 030204 cardiovascular system & hematology Risk Assessment Article 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Risk Factors Internal medicine medicine Humans Pharmacology (medical) Myocardial infarction Stroke Ischemic Stroke Pharmacology business.industry Cholesterol Incidence (epidemiology) General Medicine Guideline Atherosclerosis medicine.disease United States 030104 developmental biology chemistry Cardiovascular Diseases Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business Very high risk |
Zdroj: | Cardiovasc Drugs Ther |
ISSN: | 1573-7241 0920-3206 |
DOI: | 10.1007/s10557-021-07167-1 |
Popis: | PURPOSE: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline defines very high atherosclerotic cardiovascular disease (ASCVD) risk as a history of ≥2 major ASCVD events or 1 major ASCVD event and multiple high-risk conditions. We tested if a simplified approach, having a history of a major ASCVD event, would identify a high proportion of patients that meet the 2018 AHA/ACC cholesterol guideline criteria for very high risk. METHODS: We analyzed data from US adults with health insurance in the MarketScan database who had experienced an acute coronary syndrome in the past year (recent ACS, n=3,626), a myocardial infarction (MI) other than a recent ACS (n=7,572), an ischemic stroke (n=3,551) or symptomatic peripheral artery disease (PAD, n=5,919). Patients were followed from January 1, 2016 through December 31, 2017 for recurrent ASCVD events. RESULTS: Among 16,344 patients with a history of a major ASCVD event, 94.0% met the 2018 AHA/ACC cholesterol guideline definition for very high risk including 92.9%, 96.5%, 93.1%, and 96.2% with a recent ACS, history of MI, history of stroke and symptomatic PAD, respectively. The incidence of ASCVD events per 1,000 person-years was 50.4 (95% CI: 47.6-53.3) among all patients with a history of a major ASCVD event versus 53.1 (95% CI: 50.1-56.1) among patients who met the 2018 AHA/ACC cholesterol guideline definition of very high risk. CONCLUSION: The vast majority of patients with a recent ACS, history of MI, ischemic stroke or symptomatic PAD meet the 2018 AHA/ACC cholesterol guideline definition of very high risk. |
Databáze: | OpenAIRE |
Externí odkaz: |